Skip to main content
Explore URMC


URMC Related Haplo-identical Donor BMT (HaploOnly)

Research Question:
How many days is it for ANCs and platelets to establish themselves after transplantation?

Basic Study Information

This study will be a single-center treatment protocol with five possible preparative regimens, designed to validate the process of related donor haploidentical-SCT at the Wilmot Cancer Institute Blood and Marrow Transplant Unit. Enrolled patients will receive chemotherapy +/- radiation as a pre-transplant conditioning regimen. Patients will then receive haploidentical stem cells, either bone marrow or mobilized peripheral blood, followed by GvHD prophylaxis that will include cyclophosphamide. Multiple data points will be collected prior to, during, and following transplantation to ensure safety of the process and to evaluate the stated objectives.

Location: University of Rochester Medical Center
Study Reference #: UBMT15056

Lead Researcher (Principal Investigator)

Lead Researcher: Jeffrey Andolina

Study Contact Information

Additional Study Details

Contact This Study

This field is required
This field is required
You must agree to be contacted to continue.

Return to Search